Priscilla A. Hollander
Baylor Endocrine Center
Dallas
TX 75246
USA
Name/email consistency: high
- Controversies in prediabetes: do we have a diagnosis? Hollander, P., Spellman, C. Postgrad. Med (2012)
- Efficacy and safety of insulin detemir once daily in combination with sitagliptin and metformin: the TRANSITION randomized controlled trial. Hollander, P., Raslova, K., Skjøth, T.V., Råstam, J., Liutkus, J.F. Diabetes. Obes. Metab (2011)
- Effect of rimonabant on glycemic control in insulin-treated type 2 diabetes: the ARPEGGIO trial. Hollander, P.A., Amod, A., Litwak, L.E., Chaudhari, U. Diabetes. Care (2010)
- Titration of inhaled human insulin (Exubera) in a treat-to-target regimen for patients with type 2 diabetes. Hollander, P.A., Cefalu, W.T., Mitnick, M., Lawrence, D., Rosenstock, J. Diabetes Technol. Ther. (2010)
- Saxagliptin added to a thiazolidinedione improves glycemic control in patients with type 2 diabetes and inadequate control on thiazolidinedione alone. Hollander, P., Li, J., Allen, E., Chen, R. J. Clin. Endocrinol. Metab. (2009)
- A 52-week, multinational, open-label, parallel-group, noninferiority, treat-to-target trial comparing insulin detemir with insulin glargine in a basal-bolus regimen with mealtime insulin aspart in patients with type 2 diabetes. Hollander, P., Cooper, J., Bregnhøj, J., Pedersen, C.B. Clin. Ther (2008)
- Evolution of a pulmonary insulin delivery system (Exubera) for patients with diabetes. Hollander, P.A. MedGenMed (2007)
- Endocannabinoid blockade for improving glycemic control and lipids in patients with type 2 diabetes mellitus. Hollander, P. Am. J. Med. (2007)
- Body weight changes associated with insulin therapy: a retrospective pooled analysis of inhaled human insulin (Exubera) versus subcutaneous insulin in five controlled Phase III trials. Hollander, P.A., Krasner, A., Klioze, S., Schwartz, P., Duggan, W. Diabetes. Care (2007)
- Low-dose rosiglitazone in patients with insulin-requiring type 2 diabetes. Hollander, P., Yu, D., Chou, H.S. Arch. Intern. Med. (2007)
- Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial. Hollander, P.A., Blonde, L., Rowe, R., Mehta, A.E., Milburn, J.L., Hershon, K.S., Chiasson, J.L., Levin, S.R. Diabetes. Care (2004)